ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,256.03
0.85%
Dow Jones
39,935.07
0.00%
Gold vs US Dollar
2,374.695
0.44%
Brent Oil
81.045
-0.60%
Bitcoin
67,375.49
2.41%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
26/07/202413:28UK RegulatoryAlliance Trust PLC - Net Asset ValueLSE:ATSTAlliance Trust Plc
26/07/202413:27Alliance NewsAlliance NewsIN BRIEF: Astra pushes to get Imfinzi approved for lung cancer in USLSE:AZNAstrazeneca Plc
26/07/202413:27Alliance NewsAlliance NewsIN BRIEF: Astra pushes to get Imfinzi approved for lung cancer in USLSE:AZNAstrazeneca Plc
26/07/202413:27PR Newswire (US)CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
26/07/202413:25PR Newswire (US)Xinhua Silk Road: NE. China's Harbin becomes popular summer tourism destination with rich wetland resources
26/07/202413:23Alliance NewsAlliance NewsMajor economy comparative indicators
26/07/202413:15PR Newswire (US)Day One Named one of the Top Custom eLearning Development Companies Worldwide by Learning Light
26/07/202413:15PR Newswire (US)Immorta Bio Files Investigational New Drug Application for First in Class Senolytic Immunotherapy SenoVax™ for Treatment of Advanced Lung Cancer
26/07/202413:15PR Newswire (US)Align ENT + Allergy Announces Partnership with Melnick, Moffitt & Mesaros ENT Associates, Expanding Pennsylvania Footprint
26/07/202413:14PR Newswire (US)CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer
26/07/202413:12PR Newswire (US)StorageMart Introduces New Bridge Lending Program for Self Storage Facilities
26/07/202413:12PR Newswire (US)PATLive to Exhibit at the 2024 HUGE Convention in Nashville
26/07/202413:10PR Newswire (US)WesBanco, Inc. Announces Transformative Merger with Premier Financial Corp.NASDAQ:WSBCWesBanco Inc
26/07/202413:10PR Newswire (US)WesBanco, Inc. Announces Transformative Merger with Premier Financial Corp.NASDAQ:PFCPremier Financial Corporation
26/07/202413:09PR Newswire (US)Xinhua Silk Road: NE. China's Harbin becomes popular summer tourism destination with rich wetland resources
26/07/202413:05PR Newswire (US)'Dirty Dancing Days' Summer Festival at Mountain Lake Lodge, Region's Newest Day Trip, Debuts August 16 and 17
26/07/202413:00PR Newswire (US)Nature's Miracle Holding Inc. Announces Pricing of $1.2 Million Public OfferingNASDAQ:NMHINatures Miracle Holding Inc
26/07/202413:00PR Newswire (US)Promethean's ActivPanel LX wins a Tech & Learning Best of Show Award at the ISTELive 24 edtech conferenceAMEX:MYNDMynd ai Inc
26/07/202413:00PR Newswire (US)WesBanco Announces Second Quarter 2024 Financial ResultsNASDAQ:WSBCWesBanco Inc
26/07/202413:00PR Newswire (US)TDS and UScellular to release second quarter operating results and host conference call on August 2, 2024NYSE:USMUS Cellular Corp
26/07/202413:00PR Newswire (US)Aquacubed Offers Innovative Whole-House Water System with Lifetime Support
26/07/202413:00PR Newswire (US)Oppenheimer Holdings Inc. Reports Second Quarter 2024 EarningsNYSE:OPYOppenheimer Holdings Inc
26/07/202413:00PR Newswire (US)RedThread Research Launches 2 New Reports on Manager Effectiveness, with Urgent Call for Action
26/07/202413:00PR Newswire (US)SWAROVSKI PARTNERS WITH GK ELITE FOR THE USA GYMNASTICS TEAM LEOTARDS
26/07/202413:00PR Newswire (US)CougarD Soars with 115% User Surge: New Video Verification Feature Drives Unprecedented Growth
26/07/202413:00PR Newswire (US)Wire 3 Expands to Marion County
26/07/202413:00PR Newswire (US)AAM to Announce Second Quarter Financial Results on August 9NYSE:AXLAmerican Axle and Manufacturing Holdings Inc
26/07/202413:00PR Newswire (US)Woodsboro Bank Welcomes St. John Properties' Daniel Severn to Board of Directors
26/07/202413:00PR Newswire (US)Mphasis Unveils Mphasis NeoCrux™ and Mphasis NeoZeta™: A Powerful Duo for AI-Driven Software Engineering and Enterprise Modernization
26/07/202413:00PR Newswire (US)TriNet Announces Second Quarter 2024 ResultsNYSE:TNETTriNet Group Inc

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
GDR
Genedrive
LSE
PPP
Pennpetro Energy
LSE
UKOG
Uk Oil & Gas
LSE
SOLG
Solgold
LSE
BIRD
Blackbird
LSE
OCDO
Ocado
LSE
SBTX
Skinbiotherapeutics
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
EME
Empyrean Energy
LSE
NWG
Natwest
LSE
INSP
Inspirit Energy
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved